Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion.
about
The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis.Peptides with anticancer use or potential.Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agentFormation of polyomavirus-like particles with different VP1 molecules that bind the urokinase plasminogen activator receptor.Molecular and cellular basis of cancer invasion and metastasis: implications for treatment.uPA-silica-Particles (SP-uPA): a novel analytical system to investigate uPA-uPAR interaction and to test synthetic uPAR antagonists as potential cancer therapeutics.Urokinase-type plasminogen activator (uPA) and its receptor (CD87): a new target in tumor invasion and metastasis.Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice.Trypsinogen expression in human ovarian carcinomas.Blockage of the urokinase receptor on the cell surface: construction and characterization of a hybrid protein consisting of the N-terminal fragment of human urokinase and human albumin.Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells.Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size.Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator.
P2860
Q34165118-8FDF7828-5B7B-427D-82C3-59C55EABC256Q35167010-BCD0160F-0710-4726-95DD-D56EC768E1EDQ36081353-BDD0B6C9-F232-49A4-969F-E94FAD6D1560Q40012120-62E02734-158A-436D-B447-104436958BC7Q40574779-B06F8119-680F-4CF5-BB6F-49C2A5842257Q40740643-B4F7D893-8009-4F75-9EA0-D0392AEB82B2Q40942602-31B559FA-55D0-4638-A84E-5DA7195EA0DBQ41028790-6512E0BF-B99A-464F-93BD-C1282D435A25Q41283685-63856082-3D1B-4EEF-8F3C-9F192956252DQ41411673-5D8F99E3-ED8E-4FE2-AC73-CE9AFAE90414Q41495024-A9C0BE17-3FB5-428B-BBFE-6DB1408147A8Q47251534-3D571DC8-5AD4-439F-A40F-99182357EC59Q54521551-26A005B5-BC94-4BE1-86FC-DB54684B4837
P2860
Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Saturation of tumour cell surf ...... d basement membranes invasion.
@ast
Saturation of tumour cell surf ...... d basement membranes invasion.
@en
type
label
Saturation of tumour cell surf ...... d basement membranes invasion.
@ast
Saturation of tumour cell surf ...... d basement membranes invasion.
@en
prefLabel
Saturation of tumour cell surf ...... d basement membranes invasion.
@ast
Saturation of tumour cell surf ...... d basement membranes invasion.
@en
P2093
P2860
P356
P1476
Saturation of tumour cell surf ...... d basement membranes invasion.
@en
P2093
Chucholowski N
Goretzki L
Kobayashi H
Shinohara H
Sugimura M
P2860
P2888
P304
P356
10.1038/BJC.1993.99
P407
P577
1993-03-01T00:00:00Z
P5875
P6179
1029032298